Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Epigenetic silencing of
tumour suppressor
genes (TSG) inactivates TSG functions. Previously, we identified
PCDH10
as a methylated TSG in carcinomas. Here, we detected its frequent silencing and methylation in lymphoma cell lines including 100% Burkitt, 100% diffuse large B cell, 86% Hodgkin, 100% nasal natural killer/T-cell lymphoma and 1/3 of leukaemia cell lines, and in primary tumours but not in normal peripheral blood mononuclear cells or lymph nodes.
PCDH10
silencing could be reversed by demethylation with 5-aza-2'-deoxycytidine. Methylation was further detected in 14% of Hodgkin lymphoma sera. Thus,
PCDH10
methylation is frequently involved in lymphomagenesis and could serve as a tumour-specific biomarker.
...
PMID:Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. 1734 Dec 68
PCDH10
(protocadherin-10), a novel
tumour suppressor
gene, is down-regulated in several human cancers due to hypermethylation of promoter CGIs (CpG islands). Here, we investigated the expression of
PCDH10
in different normal adult tissues and in a panel of prostate cancer cell lines.
PCDH10
was widely expressed in normal tissues with higher levels in the prostate. The expression of
PCDH10
was markedly reduced or silenced in prostate cancer cell lines compared with normal adult prostate tissue. Decreased
PCDH10
expression was correlated with the methylation status of the
PCDH10
promoter. Furthermore, the DNA demethylating agent 5'-azacytidin restored
PCDH10
expression by suppressing
PCDH10
promoter methylation in prostate cancer cell lines. Treatment with Trichostatin A alone had no significant effect on the expression of
PCDH10
but enhanced the effect of 5'-azacytidin. In conclusion, we found that the decreased
PCDH10
expression in prostate cancer cells was associated with the aberrant methylation of
PCDH10
promoter CGI. Our results may contribute to the understanding of the role of
PCDH10
inactivation in the progression of prostate cancers.
...
PMID:Epigenetic inactivation of PCDH10 in human prostate cancer cell lines. 2131 42